LEXEO THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15.46 USD | -0.13% |
|
+10.27% | +15.20% |
Chart calendar Lexeo Therapeutics, Inc.
1e7d2d7679d7ee47081441c.djbUfQU04P8iGQUsH6W_aPzl37ahz0dZWfKGKOBAGFc.JGWsIjBfgpBmKjUbXtePEbGWmtjIjT5hPsTLWLoBKnozbr0lY323kElGVA~8fa324d887e846696afea640fbde2a56
Past events on Lexeo Therapeutics, Inc.
| 15/05/2024 16:40 | BofA Securities Health Care Conference |
| 14/05/2024 16:00 | RBC Capital Markets Global Healthcare Conference |
| 13/05/2024 14:00 | Citizens JMP Life Sciences Conference |
| 09/05/2024 12:00 | Q1 2024 Earnings Release |
| 11/03/2024 17:20 | Leerink Partners Global Biopharma Conference |
| 11/03/2024 11:42 | Q4 2023 Earnings Release |
| 10/01/2024 16:15 | JPMorgan Healthcare Conference |
| 11/12/2023 12:00 | Q3 2023 Earnings Release |
Annual results
| Fiscal Period | December | 2022 | 2023 | 2024 |
|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | -68,2 -72,4 5.73% | 0,00 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -68,5 -72,0 4.88% | -92,5 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -66,4 -69,4 4.33% | -76,5 |
|
Net income Million USD | Released Forecast Spread | -59,3 | -66,4 -69,3 4.24% | -74,6 |
|
EPS USD | Released Forecast Spread | -36,3 | -12,4 -4,92 -152.06% | -2,50 |
| Announcement Date | 29/09/23 | 11/03/24 | - |
Quarterly results
| Fiscal Period | December | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | -20,1 -15,0 -34.11% | -23,2 -18,0 -29.01% | ||||||
|
EBIT Million USD | Released Forecast Spread | -20,3 -16,0 -26.71% | -15,0 -18,6 19.49% | -23,3 -19,0 -22.58% | -26,0 | -28,0 | -30,0 | -33,0 | -36,0 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -20,1 -15,0 -34.05% | -14,2 -17,2 17.52% | -21,7 -18,5 -17.2% | -22,0 | -24,0 | -26,0 | ||
|
Net income Million USD | Released Forecast Spread | -20,1 -15,0 -34.05% | -14,2 -16,5 13.94% | -21,7 -18,4 -17.88% | -18,2 | -18,2 | -14,7 | ||
|
EPS USD | Released Forecast Spread | -1,22 -0,90 -36.24% | -0,71 | -0,77 -0,76 -1.32% | -0,60 | -0,57 | -0,51 | ||
| Announcement Date | 11/12/23 | 11/03/24 | 09/05/24 | - | - | - | - | - |
| 30/06/2024 | IMMUNOVANT, INC.: Q4 2024 Earnings Release (Projected) |
| 15/07/2024 06:45 | ADDLIFE AB: Q2 2024 Earnings Release |
| 21/07/2024 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
| 23/07/2024 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected) |
| 23/07/2024 | ALKERMES PLC: Q2 2024 Earnings Release (Projected) |
| 23/07/2024 | IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected) |
| 23/07/2024 | ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release (Projected) |
| 24/07/2024 | LONZA GROUP AG: Q2 2024 Earnings Release |
| 25/07/2024 06:00 | BACHEM HOLDING AG: Q2 2024 Earnings Release |
| 25/07/2024 | PHARVARIS N.V.: Q2 2024 Earnings Release (Projected) |
Past sector events for Lexeo Therapeutics, Inc.
| 23/05/2024 12:00 | CUREVAC N.V.: Q1 2024 Earnings Release |
| 22/05/2024 06:00 | EVOTEC SE: Q1 2024 Earnings Release |
| 21/05/2024 22:14 | ALVOTECH: Q1 2024 Earnings Release |
| 21/05/2024 12:00 | EXSCIENTIA PLC: Q1 2024 Earnings Release |
| 17/05/2024 07:00 | BIOARCTIC AB: Q1 2024 Earnings Release |
| 15/05/2024 21:05 | CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 14/05/2024 | GNI GROUP LTD.: Q1 2024 Earnings Release |
| 14/05/2024 21:05 | NUVATION BIO INC.: Q1 2024 Earnings Release |
| 14/05/2024 12:30 | ABSCI CORPORATION: Q1 2024 Earnings Release |
| 14/05/2024 06:50 | BELITE BIO, INC: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- LXEO Stock
- Calendar Lexeo Therapeutics, Inc.
